FLEXOCTA Trademark

Trademark Overview

On Thursday, July 24, 2014, a trademark application was filed for FLEXOCTA with the United States Patent and Trademark Office. The USPTO has given the FLEXOCTA trademark a serial number of 79152766. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 24, 2024. This trademark is owned by Novo Nordisk Health Care AG. The FLEXOCTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hemostasis management
flexocta

General Information

Serial Number79152766
Word MarkFLEXOCTA
Filing DateThursday, July 24, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 24, 2024
Registration Number4693931
Registration DateTuesday, March 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for hemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, October 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 10, 2014APPLICATION FILING RECEIPT MAILED
Thursday, November 6, 2014ASSIGNED TO EXAMINER
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Thursday, October 2, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, November 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 26, 2014NOTICE OF PUBLICATION
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, April 2, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Saturday, May 16, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 17, 2021CANCELLED SECTION 71
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Saturday, May 16, 2015FINAL DISPOSITION PROCESSED
Friday, June 5, 2015NOTIFICATION PROCESSED BY IB
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 17, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 10, 2022INVALIDATION PROCESSED
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, September 4, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 14, 2025DEATH OF INTERNATIONAL REGISTRATION
Wednesday, August 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

flexocta management hemostasis preparations pharmaceutical